Debating The Risks, Benefits Of A Controversial Alzheimer's Drug

Debating the risks, benefits of a controversial Alzheimer's drug

CBC News: The National

The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ

The Wall Street Journal

The Alzheimer’s Treatment Controversy: Implications of Accelerated Drug Approvals

Harvard T.H. Chan School of Public Health

Controversy over newly approved Alzheimer's drug

Implications of Aducanumab, the New Alzheimer's Drug with Gil Rabinovici and Rita Redberg

UCSF Department of Medicine

Why the FDA approved a controversial Alzheimer's drug

How new Alzheimer's drug Leqembi works, risks and who might benefit

LIVE: The Alzheimer’s Treatment Controversy

Medical expert: New Alzheimer’s drug gives patients hope

Experimental Alzheimer's drug shows benefits in phase 3 trial

Statin Misinformation: Mayo Clinic Radio

The Truth About Dietary Cholesterol | Dr. Peter Attia & Dr. Andrew Huberman

Huberman Lab Clips

US approves controversial new Alzheimer’s drug

Al Jazeera English

FDA approves controversial Biogen Alzheimer's drug | DW News

FDA Approves 'Controversial' New Alzheimer's Drug

Aduhelm is FDA Approved for Alzheimer's, But Does it Work?

Healthcare Triage

What is the controversy over Aducanumab/Aduhelm for Alzheimer's?

Mount Sinai Decides Against Using Controversial Alzheimer's Drug

FDA approves Alzheimer’s drug debated by experts

Associated Press

New drugs show small but positive results in fight against Alzheimer’s